title: Cat scratch disease associated with retinal vein occlusion.
authors.forename: Avi
authors.initials: A
authors.lastname: Rubinov
authors.forename: Eytan Z
authors.initials: EZ
authors.lastname: Blumenthal
authors.forename: Itzchak
authors.initials: I
authors.lastname: Beiran
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D018416:Bartonella henselae / Q000302:isolation & purification*; D000068258:Bevacizumab; D002372:Cat-Scratch Disease / Q000150:complications / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D004318:Doxycycline / Q000008:administration & dosage*; D005451:Fluorescein Angiography / Q000379:methods; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D012170:Retinal Vein Occlusion / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D012293:Rifampin / Q000008:administration & dosage*; D041623:Tomography, Optical Coherence / Q000379:methods; D016896:Treatment Outcome; D014786:Vision Disorders / Q000209:etiology
chemical_list: D020533:Angiogenesis Inhibitors; D000900:Anti-Bacterial Agents; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004318:Doxycycline; D012293:Rifampin